Equities research analysts expect bluebird bio (NASDAQ:BLUE) to post $5.77 million in sales for the current fiscal quarter, according to Zacks. Six analysts have provided estimates for bluebird bio’s earnings, with estimates ranging from $4.14 million to $8.90 million. bluebird bio posted sales of $6.83 million in the same quarter last year, which would indicate […]